Guyana Vaccine Industry Outlook 2024 - 2028

See how Guyana Vaccine performed compared to key markets.

Key Market Indicators

Guyanese vaccination coverage for children aged one year old is projected to reach 99% by 2028, up from the current 97% in 2023. This growth represents an average annual increase of 0.4 percentage points. Since 1985, the vaccination coverage in Guyana has been rising at an annual rate of 0.6 percentage points. In terms of vaccine imports, Guyana is expected to see its expenditures reach approximately $3.57 million by 2028, up from $3.03 million in 2023. This reflects an average annual growth rate of 2.5%. Since 1997, the demand for vaccines in the country has been increasing at an average rate of 3.4% per year. On the export front, Guyanese vaccine exports plummeted to $2,480 in 2018, a sharp decline from $10,280 in 2017, marking a 75.8% decrease year over year.

Guyana Vaccine Market Data and Forecasts

How much will Guyana Vaccine Market grow to 2028?

Forecast: Import of Vaccines for Human Use to Guyana
Forecast: Import of Vaccines for Human Use to Guyana
Forecast: Diphtheria Tetanus Toxoid and Pertussis Third Dose (DTP3) Immunization Coverage in Guyana
Forecast: Polio Vaccine Third Dose (Pol3) Immunization Coverage in Guyana

Other Top Countries about Vaccine